Ovation Science Statistics
Total Valuation
Ovation Science has a market cap or net worth of CAD 1.54 million. The enterprise value is 1.81 million.
| Market Cap | 1.54M |
| Enterprise Value | 1.81M |
Important Dates
The last earnings date was Thursday, November 27, 2025.
| Earnings Date | Nov 27, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Ovation Science has 38.41 million shares outstanding. The number of shares has increased by 2.27% in one year.
| Current Share Class | 38.41M |
| Shares Outstanding | 38.41M |
| Shares Change (YoY) | +2.27% |
| Shares Change (QoQ) | +0.75% |
| Owned by Insiders (%) | 23.46% |
| Owned by Institutions (%) | n/a |
| Float | 29.40M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 24.08 |
| PB Ratio | -1.08 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | 491.51 |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -4.34 |
| EV / Sales | 28.36 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.02
| Current Ratio | 0.02 |
| Quick Ratio | 0.01 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -8.56 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -578.74% |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | 31.43% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 1.33 |
| Inventory Turnover | 0.54 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +60.00% in the last 52 weeks. The beta is 0.45, so Ovation Science's price volatility has been lower than the market average.
| Beta (5Y) | 0.45 |
| 52-Week Price Change | +60.00% |
| 50-Day Moving Average | 0.04 |
| 200-Day Moving Average | 0.04 |
| Relative Strength Index (RSI) | 49.62 |
| Average Volume (20 Days) | 26,142 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Ovation Science had revenue of CAD 63,819 and -417,018 in losses. Loss per share was -0.01.
| Revenue | 63,819 |
| Gross Profit | 51,984 |
| Operating Income | -445,225 |
| Pretax Income | -417,018 |
| Net Income | -417,018 |
| EBITDA | -443,786 |
| EBIT | -445,225 |
| Loss Per Share | -0.01 |
Balance Sheet
The company has 2,585 in cash and 276,195 in debt, giving a net cash position of -273,610 or -0.01 per share.
| Cash & Cash Equivalents | 2,585 |
| Total Debt | 276,195 |
| Net Cash | -273,610 |
| Net Cash Per Share | -0.01 |
| Equity (Book Value) | -1.42M |
| Book Value Per Share | -0.04 |
| Working Capital | -1.42M |
Cash Flow
| Operating Cash Flow | 3,126 |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
| Gross Margin | 81.46% |
| Operating Margin | -697.64% |
| Pretax Margin | -653.44% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
Ovation Science does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -2.27% |
| Shareholder Yield | -2.27% |
| Earnings Yield | -27.14% |
| FCF Yield | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Ovation Science has an Altman Z-Score of -468.85 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -468.85 |
| Piotroski F-Score | 4 |